Status:
COMPLETED
Anxiety Reduction in Type 2 Diabetes Through Breathing ExercisesPatients With Type 2 Diabetes
Lead Sponsor:
Goztepe Prof Dr Suleyman Yalcın City Hospital
Conditions:
Type 2 Diabetes
Type 2 Diabetes Treated With Insulin
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Injection-related anxiety is a significant barrier to the management of type 2 diabetes, adversely affecting treatment adherence and glycemic control. This study investigated the effectiveness of brea...
Detailed Description
This study is designed as a randomized, double-blind, experimental study. Data from patients who agree to participate in the study was collected by the researcher prior to testing. Variables collected...
Eligibility Criteria
Inclusion
- type 2 diabetes diagnosis for at least one year,
- followed up at the diabetes outpatient clinic,
- literate and able to understand and complete study forms,
- first-time insulin injectors in addition to oral antidiabetics,
Exclusion
- younger than 18 years
- older than 65 years
- having visual, auditory, or mental impairments that would affect to complete the forms
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT06519903
Start Date
May 1 2022
End Date
December 31 2022
Last Update
July 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SB Istanbul Goztepe Prof Dr Suleyman Yalcin City Hospital
Istanbul, Turkey (Türkiye)